综述了作为抗凝血材料的丝素蛋白的改性方法,重点讨论了用s-羧甲基还原角蛋白、硫酸、二氧化硫和vWf(Von Willebrand fator)因子的抗体等对丝素蛋白的改性,并分析了改性材料的抗凝血机理和抗凝血性能.
参考文献
[1] | 林思聪.高分子生物材料分子工程研究进展[J].高分子通报,1997(01):1. |
[2] | 宁丽;薛淼;孙皎.医用皮肤再生膜等材料在三个水平生物学实验结果的性关性探讨[A].北京,1998:24. |
[3] | 朱祥瑞.家蚕丝素固定化果胶酶的研究[J].浙江农业大学学报,1998(01):74. |
[4] | Lee K Y;Kong S J .Effect of surface properties on the antithrombogenicity of silk fibroin/S-carboxymethyl kerateine blend films[J].Journal of Biomaterials Science-Polymer Edition,1998,9:905. |
[5] | 玉田靖 .素材利用した人工腱、韧带用材料の开发[J].蚕丝の光,1997,50(08):26. |
[6] | 孔祥东,朱良均,闵思佳.丝素蛋白在生物材料上的研究和应用[J].功能材料,2001(06):583-585. |
[7] | 周耀祖 .蚕丝在医药领域的开发利用[J].蚕桑通报,1998,29(03):62. |
[8] | Ishihara K;Aragaki R;Ueda T et al.Reduced thrombogenicity of polymers having phospholipid polar groups[J].Journal of Biomedical Materials Research,1990,24(08):1069. |
[9] | Ishihara K;Oshida H;Endo Y et al.Hemocompatibility of human whole blood on polymers with a phospholipid polar groups and its mechanism[J].Journal of Biomedical Materials Research,1992,26:1543. |
[10] | Furuzono T;Ishihara K;Nakabayashi N;Tamada Y .Chemical modification of silk fibroin with 2-methacryloyloxyethyl phosphorylcholine. II. Graft-polymerization onto fabric through 2-methacryloyloxyethyl isocyanate and interaction between fabric and platelets.[J].Biomaterials,2000(4):327-333. |
[11] | Paulo A S .Searching for alternatives to heparin sulfated fucans from marine invertebrates[J].Traditional Chinese medicine,1999,9(08):225. |
[12] | 程忠玲,王松.丝素膜上接枝褐藻多糖硫酸酯及其体外抗凝血性能的研究[J].精细化工,2004(04):282-284,296. |
[13] | 郑军,杨红,王英,钱俊杰,李玉新,夏明.褐藻糖胶抗血栓研究进展[J].中国海洋药物,2002(02):53-59. |
[14] | Gu J W;Yang X L et al.Surface sulfonation of silk fibroin film by plasma tretment and in vitro antithrombogenicity study[J].Materials Science and Engineering C,2002,782:229. |
[15] | 高运华,杨新林,范翠红,李茂林,朱鹤孙.丝素蛋白膜上vWf抗体的固定化及其体外抗凝血性能[J].高技术通讯,2003(03):56-59. |
[16] | 李茂林,杨新林,范翠红,曾任平,朱鹤孙.SPA用于丝素膜的生物改性研究[J].高技术通讯,2003(04):67-71. |
上一张
下一张
上一张
下一张
计量
- 下载量()
- 访问量()
文章评分
- 您的评分:
-
10%
-
20%
-
30%
-
40%
-
50%